# SampleID	BarcodeSequence	LinkerPrimerSequence	ReversePrimer	run_prefix	pub_id	Sex	Visit	visitRank	RXCode	Description
Sample-57	TTACGC	GCGGACTACCVGGGTATCTAAT	GCACTCCTRCGGGAGGCAGCAG,GCACACCTACGGGTGGCTGC,GCACACCTACGGGTGGCAGC	JH3VWZ201	096-282	Male	9	1	T1	NYVAC (2) & placebo mo(0,1) + NYVAC (2) & AIDSVAX B/E mo(3,6)
Sample-58	TTAGGT	GCGGACTACCVGGGTATCTAAT	GCACTCCTRCGGGAGGCAGCAG,GCACACCTACGGGTGGCTGC,GCACACCTACGGGTGGCAGC	JH3VWZ201	096-282	Male	12	2	T1	NYVAC (2) & placebo mo(0,1) + NYVAC (2) & AIDSVAX B/E mo(3,6)
Sample-60	TTCCAC	GCGGACTACCVGGGTATCTAAT	GCACTCCTRCGGGAGGCAGCAG,GCACACCTACGGGTGGCTGC,GCACACCTACGGGTGGCAGC	JH3VWZ201	096-176	Female	9	1	T1	NYVAC (2) & placebo mo(0,1) + NYVAC (2) & AIDSVAX B/E mo(3,6)
Sample-61	TTGTAC	GCGGACTACCVGGGTATCTAAT	GCACTCCTRCGGGAGGCAGCAG,GCACACCTACGGGTGGCTGC,GCACACCTACGGGTGGCAGC	JH3VWZ201	096-176	Female	12	2	T1	NYVAC (2) & placebo mo(0,1) + NYVAC (2) & AIDSVAX B/E mo(3,6)
Sample-62	TTGTGT	GCGGACTACCVGGGTATCTAAT	GCACTCCTRCGGGAGGCAGCAG,GCACACCTACGGGTGGCTGC,GCACACCTACGGGTGGCAGC	JH3VWZ201	096-123	Female	12	1	T4	DNA & placebo & AIDSVAX B/E mo(0,1) + NYVAC (2) & AIDSVAX B/E mo(3,6)
Sample-63	TATCAC	GCGGACTACCVGGGTATCTAAT	GCACTCCTRCGGGAGGCAGCAG,GCACACCTACGGGTGGCTGC,GCACACCTACGGGTGGCAGC	JH3VWZ201	096-049	Female	9	1	T2	NYVAC (2) & AIDSVAX B/E mo(0,1,3,6)
Sample-64	TATGCC	GCGGACTACCVGGGTATCTAAT	GCACTCCTRCGGGAGGCAGCAG,GCACACCTACGGGTGGCTGC,GCACACCTACGGGTGGCAGC	JH3VWZ201	096-049	Female	12	2	T2	NYVAC (2) & AIDSVAX B/E mo(0,1,3,6)
Sample-66	TACTAC	GCGGACTACCVGGGTATCTAAT	GCACTCCTRCGGGAGGCAGCAG,GCACACCTACGGGTGGCTGC,GCACACCTACGGGTGGCAGC	JH3VWZ201	096-288	Female	9	1	T1	NYVAC (2) & placebo mo(0,1) + NYVAC (2) & AIDSVAX B/E mo(3,6)
Sample-67	TACGTT	GCGGACTACCVGGGTATCTAAT	GCACTCCTRCGGGAGGCAGCAG,GCACACCTACGGGTGGCTGC,GCACACCTACGGGTGGCAGC	JH3VWZ201	096-238	Female	9	1	T3	DNA & placebo (2) mo(0,1) + NYVAC (2) & AIDSVAX B/E mo(3,6)
Sample-68	TCTTAC	GCGGACTACCVGGGTATCTAAT	GCACTCCTRCGGGAGGCAGCAG,GCACACCTACGGGTGGCTGC,GCACACCTACGGGTGGCAGC	JH3VWZ201	096-238	Female	12	2	T3	DNA & placebo (2) mo(0,1) + NYVAC (2) & AIDSVAX B/E mo(3,6)
Sample-70	TCACTC	GCGGACTACCVGGGTATCTAAT	GCACTCCTRCGGGAGGCAGCAG,GCACACCTACGGGTGGCTGC,GCACACCTACGGGTGGCAGC	JH3VWZ201	096-132	Female	9	1	C3	placebo (3) mo(0,1) + placebo (2) & AIDSVAX B/E placebo mo(3,6)
Sample-71	TCGGTT	GCGGACTACCVGGGTATCTAAT	GCACTCCTRCGGGAGGCAGCAG,GCACACCTACGGGTGGCTGC,GCACACCTACGGGTGGCAGC	JH3VWZ201	096-132	Female	12	2	C3	placebo (3) mo(0,1) + placebo (2) & AIDSVAX B/E placebo mo(3,6)
Sample-72	TGTTCT	GCGGACTACCVGGGTATCTAAT	GCACTCCTRCGGGAGGCAGCAG,GCACACCTACGGGTGGCTGC,GCACACCTACGGGTGGCAGC	JH3VWZ201	096-151	Female	12	1	T4	DNA & placebo & AIDSVAX B/E mo(0,1) + NYVAC (2) & AIDSVAX B/E mo(3,6)
Sample-73	TGAAGT	GCGGACTACCVGGGTATCTAAT	GCACTCCTRCGGGAGGCAGCAG,GCACACCTACGGGTGGCTGC,GCACACCTACGGGTGGCAGC	JH3VWZ201	096-162	Male	9	1	T3	DNA & placebo (2) mo(0,1) + NYVAC (2) & AIDSVAX B/E mo(3,6)
Sample-74	TGACTT	GCGGACTACCVGGGTATCTAAT	GCACTCCTRCGGGAGGCAGCAG,GCACACCTACGGGTGGCTGC,GCACACCTACGGGTGGCAGC	JH3VWZ201	096-162	Male	12	2	T3	DNA & placebo (2) mo(0,1) + NYVAC (2) & AIDSVAX B/E mo(3,6)
Sample-75	TGACAC	GCGGACTACCVGGGTATCTAAT	GCACTCCTRCGGGAGGCAGCAG,GCACACCTACGGGTGGCTGC,GCACACCTACGGGTGGCAGC	JH3VWZ201	096-089	Male	12	1	T4	DNA & placebo & AIDSVAX B/E mo(0,1) + NYVAC (2) & AIDSVAX B/E mo(3,6)
Sample-76	TGCATT	GCGGACTACCVGGGTATCTAAT	GCACTCCTRCGGGAGGCAGCAG,GCACACCTACGGGTGGCTGC,GCACACCTACGGGTGGCAGC	JH3VWZ201	096-045	Male	9	1	T3	DNA & placebo (2) mo(0,1) + NYVAC (2) & AIDSVAX B/E mo(3,6)
Sample-77	TGGAAC	GCGGACTACCVGGGTATCTAAT	GCACTCCTRCGGGAGGCAGCAG,GCACACCTACGGGTGGCTGC,GCACACCTACGGGTGGCAGC	JH3VWZ201	096-045	Male	12	2	T3	DNA & placebo (2) mo(0,1) + NYVAC (2) & AIDSVAX B/E mo(3,6)
Sample-D	ATGGAT	GCGGACTACCVGGGTATCTAAT	GCACTCCTRCGGGAGGCAGCAG,GCACACCTACGGGTGGCTGC,GCACACCTACGGGTGGCAGC	JH3VWZ201	NA		NA	NA		
db1	AATAGC	GCGGACTACCVGGGTATCTAAT	GCACTCCTRCGGGAGGCAGCAG,GCACACCTACGGGTGGCTGC,GCACACCTACGGGTGGCAGC	JH3VWZ201	NA		NA	NA		
buffer	AACTTC	GCGGACTACCVGGGTATCTAAT	GCACTCCTRCGGGAGGCAGCAG,GCACACCTACGGGTGGCTGC,GCACACCTACGGGTGGCAGC	JH3VWZ201	NA		NA	NA		
pyro-ntc-1	AACACC	GCGGACTACCVGGGTATCTAAT	GCACTCCTRCGGGAGGCAGCAG,GCACACCTACGGGTGGCTGC,GCACACCTACGGGTGGCAGC	JH3VWZ201	NA		NA	NA		
pyro-ntc-2	AACCGT	GCGGACTACCVGGGTATCTAAT	GCACTCCTRCGGGAGGCAGCAG,GCACACCTACGGGTGGCTGC,GCACACCTACGGGTGGCAGC	JH3VWZ201	NA		NA	NA		
